ACCUMED ANNOUNCES CHANGES TO BOARD OF DIRECTORS
CHICAGO, April 2, 1998 - The Board of Directors of AccuMed International, Inc. (Nasdaq: ACMIC) today announced that it voted to increase the number of members of the Board from seven to nine and has appointed Harold S. Blue and Mark Banister to serve until the next annual meeting of stockholders in May 1998. Mr. Blue and Mr. Banister will be nominated to serve on the Board until May 1999
at the stockholder meeting.
Mr. Blue has been Chairman and CEO of ProxyMed, Inc. (Nasdaq: PILL), a healthcare information technology company, since February 1993 and was previously an AccuMed director from July 1996 to April 1997. From 1979 to 1984, Mr. Blue served as President and CEO of Budget Drugs, Inc., a retail discount pharmacy chain in Florida. In September 1984, he founded Best Generics, Inc., which was later sold to pharmaceutical manufacturer Ivax Corporation (AMEX: IVX), where Mr. Blue served as a member of the Board of Directors. Mr. Blue is also currently a director of iMall, Inc. (OTC: IIML), the largest independent mall on the Internet, and Windsor Capital Corp. (OTC: WDSC), a specialty mall-based retailer.
Mr. Banister has been an independent management consultant and investment advisor specializing in identifying investment opportunities in the smaller and medium company sector and assisting such companies with their development since January 1993. He has been a director of Verex Laboratories, Inc., a pharmaceutical development company based in Denver, Colorado, since January 1993. Mr. Banister previously held senior positions at Bisgood Bishop Ltd. and
Morgan Stanley International in London. England. |
